DK1152753T3 - Kombinationer af formoterol og fluticasonpropionat til astma - Google Patents

Kombinationer af formoterol og fluticasonpropionat til astma

Info

Publication number: DK1152753T3
Authority: DK; Denmark
Prior art keywords: formoterol; asthma; combinations; fluticasone propionate; fluticasone
Prior art date: 1999-02-18

Application number

DK00907572T

Other languages

Danish (da)

English (en)

Inventor

Jeremy Guy Clarke

Henry Luke Danahay

Ian Francis Hassan

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-18

Filing date

2000-02-16

Publication date

2004-08-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10848051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1152753(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-02-16 Application filed by Novartis Ag filed Critical Novartis Ag

2004-08-16 Application granted granted Critical

2004-08-16 Publication of DK1152753T3 publication Critical patent/DK1152753T3/da

Links

208000006673 asthma Diseases 0.000 title 1
WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title 1
229940021593 formoterol and fluticasone Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK00907572T 1999-02-18 2000-02-16 Kombinationer af formoterol og fluticasonpropionat til astma DK1152753T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9903759.0A GB9903759D0 (en)	1999-02-18	1999-02-18	Organic compounds
PCT/EP2000/001270 WO2000048587A1 (fr)	1999-02-18	2000-02-16	Combinaisons de formoterol et de fluticasone propionate pour le traitement de l'asthme

Publications (1)

Publication Number	Publication Date
DK1152753T3 true DK1152753T3 (da)	2004-08-16

Family

ID=10848051

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00907572T DK1152753T3 (da)	1999-02-18	2000-02-16	Kombinationer af formoterol og fluticasonpropionat til astma

Country Status (32)

Country	Link
US (4)	US20020103260A1 (fr)
EP (1)	EP1152753B1 (fr)
JP (1)	JP2002537249A (fr)
KR (2)	KR20010102205A (fr)
CN (1)	CN1339965A (fr)
AR (1)	AR022609A1 (fr)
AT (1)	ATE266393T1 (fr)
AU (1)	AU758999B2 (fr)
BR (1)	BR0008276A (fr)
CA (1)	CA2368537A1 (fr)
CO (1)	CO5140098A1 (fr)
CZ (1)	CZ20012976A3 (fr)
DE (1)	DE60010662T2 (fr)
DK (1)	DK1152753T3 (fr)
ES (1)	ES2220411T3 (fr)
GB (1)	GB9903759D0 (fr)
HK (1)	HK1042429A1 (fr)
HU (1)	HUP0200852A3 (fr)
ID (1)	ID29437A (fr)
IL (1)	IL144061A (fr)
MY (1)	MY126768A (fr)
NO (1)	NO20013987L (fr)
NZ (1)	NZ513526A (fr)
PE (1)	PE20001545A1 (fr)
PL (1)	PL349856A1 (fr)
PT (1)	PT1152753E (fr)
RU (1)	RU2249454C2 (fr)
SK (1)	SK11842001A3 (fr)
TR (1)	TR200102110T2 (fr)
TW (1)	TWI229601B (fr)
WO (1)	WO2000048587A1 (fr)
ZA (1)	ZA200105391B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9616237D0 (en)	1996-08-01	1996-09-11	Norton Healthcare Ltd	Aerosol formulations
FR2798290B1 (fr)	1999-09-11	2003-09-12	Glaxo Group Ltd	Formulation pharmaceutique de propionate de fluticasone
GB2392164B (en) *	1999-09-11	2004-04-07	Glaxo Group Ltd	Pharmaceutical formulation of fluticasone propionate
GB2388843B (en) *	1999-09-11	2004-03-03	Glaxo Group Ltd	A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
AU2001252350A1 (en) *	2000-04-13	2001-10-30	Innovata Biomed Limited	Medicaments for treating respiratory disorders comprising formoterol and fluticasone
GB0009591D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Medical combinations
GB0012260D0 (en)	2000-05-19	2000-07-12	Astrazeneca Ab	Novel composition
US6759398B2 (en) *	2000-08-05	2004-07-06	Smithkline Beecham Corporation	Anti-inflammatory androstane derivative
FI20002216A0 (fi)	2000-10-06	2000-10-06	Orion Yhtymae Oyj	Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi)	2000-10-06	2000-10-06	Orion Yhtymae Oyj	Yhdistelmäpartikkelit
BR0207062A (pt) *	2001-02-06	2004-10-05	Innovata Biomed Ltd	Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal
GB0106031D0 (en) *	2001-03-12	2001-05-02	Glaxo Group Ltd	Use
DK1372608T3 (da) *	2001-03-30	2007-12-27	Jagotec Ag	Medicinske aerosolformuleringer
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US7931022B2 (en)	2001-10-19	2011-04-26	Respirks, Inc.	Method and apparatus for dispensing inhalator medicament
JP2005523268A (ja) †	2002-02-04	2005-08-04	グラクソ　グループ　リミテッド	グルココルチコイドおよびβ２−アドレナリン受容体アゴニストを含む吸入用製剤
EP1757281A3 (fr) *	2002-02-04	2009-07-15	Glaxo Group Limited	Formulation pour inhalation comprenant un glucocorticoïde et un agoniste de 2-adrénorécepteur béta
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
US20050158248A1 (en) *	2002-08-21	2005-07-21	Xian-Ming Zeng	Method of preparing dry powder inhalation compositions
EA007377B1 (ru)	2002-08-21	2006-10-27	Нортон Хелткэа Лтд.	Композиции для ингаляции
JP4744876B2 (ja) *	2002-08-21	2011-08-10	ノートン・ヘルスケアーリミテッド	乾燥粉末吸入組成物の製造方法
GB0219511D0 (en) *	2002-08-21	2002-10-02	Norton Healthcare Ltd	Method of preparing dry powder inhalation compositions
WO2004028545A1 (fr) *	2002-09-25	2004-04-08	Astrazeneca Ab	Combinaison d'un agoniste $g(b)2 a action prolongee et d'un glucocorticosteroide dans le traitement de maladies fibrotiques
SE527069C2 (sv) *	2003-06-19	2005-12-13	Mederio Ag	Förfarande och anordning för administrering av läkemedelspulver
SE526850C2 (sv) *	2003-06-19	2005-11-08	Microdrug Ag	Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd
SE527200C2 (sv) *	2003-06-19	2006-01-17	Microdrug Ag	Inhalatoranordning samt kombinerade doser av formaterol och fluticason
SE526509C2 (sv) *	2003-06-19	2005-09-27	Microdrug Ag	Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
SE527189C2 (sv) *	2003-06-19	2006-01-17	Microdrug Ag	Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
GB0323684D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0323685D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
RU2431501C2 (ru) *	2005-07-14	2011-10-20	Липотера, Инк.	Липолитические составы с пролонгированным высвобождением для локального лечения отложения жировых тканей
GB0617171D0 (en) *	2006-08-31	2006-10-11	Generics Uk Ltd	Novel compositions and methods
WO2008137446A1 (fr) *	2007-05-03	2008-11-13	Trustees Of Boston University	Procédés et compositions pour le traitement des maladies respiratoires
ES2774367T3 (es) *	2009-05-29	2020-07-20	Pearl Therapeutics Inc	Composiciones para el suministro respiratorio de agentes activos y métodos y sistemas asociados
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918150D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved formulations
GB0918149D0 (en)	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation
WO2011093811A2 (fr) *	2010-01-29	2011-08-04	Mahmut Bilgic	Préparations pharmaceutiques comprenant du formotérol et du fluticasone
AU2011315315B2 (en) *	2010-10-12	2016-08-18	Cipla Limited	Pharmaceutical composition
CA2835927A1 (fr) *	2011-05-17	2012-11-22	Pearl Therapeutics, Inc.	Compositions, procedes et systemes d'administration par voie respiratoire d'au moins deux agents actifs
KR20150002774A (ko)	2012-04-11	2015-01-07	시플라 리미티드	아르포르모테롤 및 플루티카손 푸로에이트를 포함하는 약학 조성물
US20140275517A1 (en)	2013-03-15	2014-09-18	Pearl Therapeutics, Inc.	Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL95590A (en) *	1989-09-08	1996-06-18	Glaxo Group Ltd	Medicinal preparations containing Salmetrol and Pluticasone Propionate
SE9302777D0 (sv) *	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
US5658549A (en) *	1991-12-12	1997-08-19	Glaxo Group Limited	Aerosol formulations containing propellant 134a and fluticasone propionate
CA2123909C (fr) *	1991-12-18	2002-10-01	Christer Carl Gustav Carling	Nouvelle combinaison de formoterol et de budesonide
GB9426252D0 (en) *	1994-12-24	1995-02-22	Glaxo Group Ltd	Pharmaceutical composition
SE9700135D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
EP1014943B1 (fr) *	1997-02-05	2002-06-19	Jago Research Ag	Formulations medicales pour aerosols
NZ337443A (en) *	1997-03-20	2001-04-27	Schering Corp	Preparation of powder agglomerates for the production of agglomerated dosage forms suitable for oral and/or nasal inhalation especially for pharmaceuticals of particle size less than 10 microns forming an inter particle bridge between agglomerates

1999
- 1999-02-18 GB GBGB9903759.0A patent/GB9903759D0/en not_active Ceased
2000
- 2000-01-27 TW TW089101371A patent/TWI229601B/zh not_active IP Right Cessation
- 2000-02-11 CO CO00009234A patent/CO5140098A1/es unknown
- 2000-02-16 HU HU0200852A patent/HUP0200852A3/hu unknown
- 2000-02-16 RU RU2001124599/15A patent/RU2249454C2/ru not_active IP Right Cessation
- 2000-02-16 DE DE60010662T patent/DE60010662T2/de not_active Revoked
- 2000-02-16 CZ CZ20012976A patent/CZ20012976A3/cs unknown
- 2000-02-16 JP JP2000599379A patent/JP2002537249A/ja active Pending
- 2000-02-16 AR ARP000100659A patent/AR022609A1/es unknown
- 2000-02-16 DK DK00907572T patent/DK1152753T3/da active
- 2000-02-16 CA CA002368537A patent/CA2368537A1/fr not_active Abandoned
- 2000-02-16 AT AT00907572T patent/ATE266393T1/de not_active IP Right Cessation
- 2000-02-16 BR BR0008276-7A patent/BR0008276A/pt not_active Application Discontinuation
- 2000-02-16 EP EP00907572A patent/EP1152753B1/fr not_active Revoked
- 2000-02-16 PE PE2000000119A patent/PE20001545A1/es not_active Application Discontinuation
- 2000-02-16 KR KR1020017010434A patent/KR20010102205A/ko not_active Ceased
- 2000-02-16 ES ES00907572T patent/ES2220411T3/es not_active Expired - Lifetime
- 2000-02-16 CN CN00803855A patent/CN1339965A/zh active Pending
- 2000-02-16 TR TR2001/02110T patent/TR200102110T2/xx unknown
- 2000-02-16 IL IL14406100A patent/IL144061A/xx not_active IP Right Cessation
- 2000-02-16 NZ NZ513526A patent/NZ513526A/xx not_active IP Right Cessation
- 2000-02-16 ID IDW00200101675A patent/ID29437A/id unknown
- 2000-02-16 PL PL00349856A patent/PL349856A1/xx not_active Application Discontinuation
- 2000-02-16 WO PCT/EP2000/001270 patent/WO2000048587A1/fr not_active Application Discontinuation
- 2000-02-16 AU AU29115/00A patent/AU758999B2/en not_active Ceased
- 2000-02-16 KR KR1020077024082A patent/KR20070104955A/ko not_active Ceased
- 2000-02-16 SK SK1184-2001A patent/SK11842001A3/sk not_active Application Discontinuation
- 2000-02-16 PT PT00907572T patent/PT1152753E/pt unknown
- 2000-02-17 MY MYPI20000586A patent/MY126768A/en unknown
2001
- 2001-06-29 ZA ZA200105391A patent/ZA200105391B/en unknown
- 2001-08-15 US US09/930,337 patent/US20020103260A1/en not_active Abandoned
- 2001-08-16 NO NO20013987A patent/NO20013987L/no not_active Application Discontinuation
2002
- 2002-03-27 HK HK02102380A patent/HK1042429A1/xx not_active IP Right Cessation
2003
- 2003-11-20 US US10/718,209 patent/US20040101487A1/en not_active Abandoned
2005
- 2005-08-03 US US11/196,560 patent/US20050287079A1/en not_active Abandoned
2009
- 2009-10-19 US US12/581,532 patent/US20100034890A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CO5140098A1 (es)	2002-03-22
EP1152753A1 (fr)	2001-11-14
CA2368537A1 (fr)	2000-08-24
KR20070104955A (ko)	2007-10-29
SK11842001A3 (sk)	2001-12-03
HK1042429A1 (en)	2002-08-16
DE60010662T2 (de)	2005-05-19
NO20013987D0 (no)	2001-08-16
BR0008276A (pt)	2001-11-06
ES2220411T3 (es)	2004-12-16
WO2000048587A1 (fr)	2000-08-24
NZ513526A (en)	2004-01-30
PL349856A1 (en)	2002-09-23
ATE266393T1 (de)	2004-05-15
AR022609A1 (es)	2002-09-04
US20020103260A1 (en)	2002-08-01
NO20013987L (no)	2001-08-16
JP2002537249A (ja)	2002-11-05
GB9903759D0 (en)	1999-04-14
CZ20012976A3 (cs)	2001-11-14
CN1339965A (zh)	2002-03-13
EP1152753B1 (fr)	2004-05-12
PE20001545A1 (es)	2001-01-29
TR200102110T2 (tr)	2001-10-22
IL144061A0 (en)	2002-04-21
HUP0200852A3 (en)	2004-04-28
US20040101487A1 (en)	2004-05-27
US20100034890A1 (en)	2010-02-11
IL144061A (en)	2005-12-18
US20050287079A1 (en)	2005-12-29
KR20010102205A (ko)	2001-11-15
ID29437A (id)	2001-08-30
AU758999B2 (en)	2003-04-03
RU2249454C2 (ru)	2005-04-10
HUP0200852A2 (en)	2002-08-28
PT1152753E (pt)	2004-09-30
AU2911500A (en)	2000-09-04
ZA200105391B (en)	2002-06-21
DE60010662D1 (de)	2004-06-17
MY126768A (en)	2006-10-31
TWI229601B (en)	2005-03-21

Publication	Publication Date	Title
DK1152753T3 (da)	2004-08-16	Kombinationer af formoterol og fluticasonpropionat til astma
NO2019030I1 (no)	2019-07-11	Formoterolfumarat dihydrat og beklometason-dipropionat - forlenget SPC
NO20040873L (no)	2004-02-27	Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
DK1210943T3 (da)	2006-09-18	Ny anvendelse af budesonid og formoterol
IS6197A (is)	2001-12-13	Aðferð og búnaður til að koma lyfjablöndum á úðaform
NO20014679L (no)	2001-09-26	Ledd/navsammenstilling og fremgangsmåte for fremstilling
DE60141247D1 (de)	2010-03-25	Bandkassette und bandeinheit
NO994778L (no)	1999-11-30	Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
DK1196409T3 (da)	2004-06-07	Respiratoriske syncytilvirusreplikationsinhibitorer
DK1353919T3 (da)	2006-11-20	Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
NO20031152D0 (no)	2003-03-13	Befruktningshindrende fremgangsmåte og administrasjonsform for det samme
NO20041004L (no)	2004-03-10	Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
DK1726658T3 (da)	2010-05-17	Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf
NO20015274L (no)	2001-12-28	ACE-2 inhiberende forbindelser og fremgangsmåter for anvendelse derav
DK1478438T3 (da)	2012-08-27	Fremgangsmåder og sammensætninger til behandling af astma
NO20033854D0 (no)	2003-09-01	N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20014648L (no)	2001-11-22	Forbindelser og metoder for behandling av astma, allergi og inflammatoriske sykdommer
NO20030899L (no)	2003-04-28	Anvendelse av salmeterol og fluticasonpropionat kombinasjon
NO20015772L (no)	2002-01-22	Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO20033506D0 (no)	2003-08-07	Parasittdrepende preparater og fremgangsmåter for anvendelse
NO20042428L (no)	2004-06-11	Multiterminal forbindelsesband og fremgangsmate for forsegling av dette
NO20010464L (no)	2001-03-23	FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO20023555D0 (no)	2002-07-25	Kromatografisk separasjonsmetode av paclitaxel og cefalomannin
DK1456377T3 (da)	2019-09-23	Syn3-sammensætninger og fremgangsmåder
NO20026065D0 (no)	2002-12-17	Prosesser for måling av dinofysistoksin og av yessotoksin